ID   CNOT4_HUMAN             Reviewed;         575 AA.
AC   O95628; B7Z6I4; E7ET38; F8VQP3; O95339; O95627; Q8IYM7; Q8NCL0;
AC   Q9NPQ1; Q9NZN6;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 162.
DE   RecName: Full=CCR4-NOT transcription complex subunit 4;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:11823428};
DE   AltName: Full=CCR4-associated factor 4;
DE   AltName: Full=E3 ubiquitin-protein ligase CNOT4;
DE   AltName: Full=Potential transcriptional repressor NOT4Hp;
DE   AltName: Full=RING-type E3 ubiquitin transferase CNOT4 {ECO:0000305};
GN   Name=CNOT4; Synonyms=NOT4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3 AND 4).
RA   Chiang P.-W.;
RT   "Isolation and characterization of human and murine homologues of
RT   yeast NOT4 gene.";
RL   Submitted (SEP-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RX   PubMed=10637334; DOI=10.1093/nar/28.3.809;
RA   Albert T.K., Lemaire M., van Berkum N.L., Gentz R., Collart M.A.,
RA   Timmers H.T.M.;
RT   "Isolation and characterization of human orthologs of yeast CCR4-NOT
RT   complex subunits.";
RL   Nucleic Acids Res. 28:809-817(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT GLY-7.
RG   The European IMAGE consortium;
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 9), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 149-575 (ISOFORM 6).
RC   TISSUE=Mammary gland, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R.,
RA   Wylie K., Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H.,
RA   Sun H., Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A.,
RA   Vanbrunt A., Nguyen C., Du F., Lamar B., Courtney L., Kalicki J.,
RA   Ozersky P., Bielicki L., Scott K., Holmes A., Harkins R., Harris A.,
RA   Strong C.M., Hou S., Tomlinson C., Dauphin-Kohlberg S.,
RA   Kozlowicz-Reilly A., Leonard S., Rohlfing T., Rock S.M.,
RA   Tin-Wollam A.-M., Abbott A., Minx P., Maupin R., Strowmatt C.,
RA   Latreille P., Miller N., Johnson D., Murray J., Woessner J.P.,
RA   Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W., Spieth J.,
RA   Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E., Cook L.L.,
RA   Hickenbotham M.T., Eldred J., Williams D., Bedell J.A., Mardis E.R.,
RA   Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K.,
RA   Simms E., Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S.,
RA   Baertsch R.A., Brent M.R., Keibler E., Flicek P., Bork P., Suyama M.,
RA   Bailey J.A., Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R.,
RA   Eddy S.R., McPherson J.D., Olson M.V., Eichler E.E., Green E.D.,
RA   Waterston R.H., Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 294-575 (ISOFORM 7).
RA   Barrow I.K.-P., Boguski M.S., Touchman J.W., Spencer F.;
RT   "Full-insert sequence of mapped XREF EST.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, UBIQUITINATION, INTERACTION WITH CNOT1
RP   AND UBIQUITIN E2 LIGASES, MUTAGENESIS OF LEU-16; CYS-17; MET-18;
RP   CYS-33; TRP-42; ARG-44; ILE-45; GLU-49; PRO-54 AND ARG-57, AND
RP   STRUCTURE BY NMR OF 1-78.
RX   PubMed=11823428; DOI=10.1093/emboj/21.3.355;
RA   Albert T.K., Hanzawa H., Legtenberg Y.I.A., de Ruwe M.J.,
RA   van den Heuvel F.A.J., Collart M.A., Boelens R., Timmers H.T.M.;
RT   "Identification of a ubiquitin-protein ligase subunit within the CCR4-
RT   NOT transcription repressor complex.";
RL   EMBO J. 21:355-364(2002).
RN   [9]
RP   INTERACTION WITH UBE2D2, AUTOUBIQUITINATION, AND MUTAGENESIS OF
RP   GLU-49.
RX   PubMed=15001359; DOI=10.1016/j.jmb.2004.01.031;
RA   Winkler G.S., Albert T.K., Dominguez C., Legtenberg Y.I., Boelens R.,
RA   Timmers H.T.;
RT   "An altered-specificity ubiquitin-conjugating enzyme/ubiquitin-protein
RT   ligase pair.";
RL   J. Mol. Biol. 337:157-165(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-71, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,
RA   Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,
RA   Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-432 AND
RP   SER-490, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   FUNCTION.
RX   PubMed=22159038; DOI=10.1096/fj.11-195875;
RA   Gronholm J., Kaustio M., Myllymaki H., Kallio J., Saarikettu J.,
RA   Kronhamn J., Valanne S., Silvennoinen O., Ramet M.;
RT   "Not4 enhances JAK/STAT pathway-dependent gene expression in
RT   Drosophila and in human cells.";
RL   FASEB J. 26:1239-1250(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-301 AND SER-432, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-475; ARG-483 AND ARG-497,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.O113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V.,
RA   Aguiar M., Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C.,
RA   Vemulapalli V., Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [17]
RP   STRUCTURE BY NMR OF 1-78 IN COMPLEX WITH ZINC IONS.
RX   PubMed=11087754; DOI=10.1074/jbc.M009298200;
RA   Hanzawa H., de Ruwe M.J., Albert T.K., van Der Vliet P.C.,
RA   Timmers H.T.M., Boelens R.;
RT   "The structure of the C4C4 ring finger of human NOT4 reveals features
RT   distinct from those of C3HC4 RING fingers.";
RL   J. Biol. Chem. 276:10185-10190(2001).
CC   -!- FUNCTION: Has E3 ubiquitin ligase activity. Involved in activation
CC       of the JAK/STAT pathway. {ECO:0000269|PubMed:11823428,
CC       ECO:0000269|PubMed:22159038}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000269|PubMed:11823428}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with CNOT1 via its C-terminus but does not
CC       stably associate with the CCR4-NOT complex. Binds E2 ubiquitin
CC       ligases via its RING domain. Interacts (via RING domain) with
CC       UBE2D2. {ECO:0000269|PubMed:11087754, ECO:0000269|PubMed:11823428,
CC       ECO:0000269|PubMed:15001359}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus
CC       {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=10;
CC       Name=1;
CC         IsoId=O95628-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95628-2; Sequence=VSP_009924;
CC       Name=3;
CC         IsoId=O95628-3; Sequence=VSP_009923;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=O95628-4; Sequence=VSP_009928;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=O95628-5; Sequence=VSP_009925, VSP_009926;
CC       Name=6;
CC         IsoId=O95628-6; Sequence=VSP_009927;
CC         Note=No experimental confirmation available.;
CC       Name=7;
CC         IsoId=O95628-7; Sequence=VSP_009929;
CC         Note=No experimental confirmation available.;
CC       Name=8;
CC         IsoId=O95628-8; Sequence=VSP_009924, VSP_009928;
CC         Note=No experimental confirmation available.;
CC       Name=9;
CC         IsoId=O95628-9; Sequence=VSP_009924, VSP_045469;
CC         Note=No experimental confirmation available. Ref.4 (BAH13270)
CC         sequence is in conflict in position: 545:V->I. {ECO:0000305};
CC       Name=10;
CC         IsoId=O95628-10; Sequence=VSP_045469;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: Autoubiquitinated. {ECO:0000269|PubMed:11823428,
CC       ECO:0000269|PubMed:15001359}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC72963.1; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=AAC72963.1; Type=Miscellaneous discrepancy; Note=Sequencing errors.; Evidence={ECO:0000305};
CC       Sequence=AAD00180.1; Type=Frameshift; Positions=358, 400; Evidence={ECO:0000305};
CC       Sequence=BAC11125.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U71267; AAD00179.1; ALT_FRAME; mRNA.
DR   EMBL; U71268; AAD00180.1; ALT_FRAME; mRNA.
DR   EMBL; AF180475; AAF29829.1; -; mRNA.
DR   EMBL; AL389980; CAB97536.1; -; mRNA.
DR   EMBL; AK074671; BAC11125.1; ALT_INIT; mRNA.
DR   EMBL; AK300365; BAH13270.1; -; mRNA.
DR   EMBL; AC083871; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC074002; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC035590; AAH35590.1; -; mRNA.
DR   EMBL; AF091094; AAC72963.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS43650.1; -. [O95628-8]
DR   CCDS; CCDS47719.1; -. [O95628-2]
DR   CCDS; CCDS55164.1; -. [O95628-4]
DR   CCDS; CCDS55165.1; -. [O95628-10]
DR   CCDS; CCDS55166.1; -. [O95628-1]
DR   CCDS; CCDS55167.1; -. [O95628-9]
DR   RefSeq; NP_001008226.1; NM_001008225.2. [O95628-2]
DR   RefSeq; NP_001177776.1; NM_001190847.1. [O95628-4]
DR   RefSeq; NP_001177777.1; NM_001190848.1. [O95628-1]
DR   RefSeq; NP_001177778.1; NM_001190849.1. [O95628-9]
DR   RefSeq; NP_001177779.1; NM_001190850.1. [O95628-10]
DR   RefSeq; NP_037448.2; NM_013316.3. [O95628-8]
DR   RefSeq; XP_016867724.1; XM_017012235.1. [O95628-10]
DR   UniGene; Hs.490224; -.
DR   PDB; 1E4U; NMR; -; A=1-78.
DR   PDB; 1UR6; NMR; -; B=12-63.
DR   PDBsum; 1E4U; -.
DR   PDBsum; 1UR6; -.
DR   ProteinModelPortal; O95628; -.
DR   SMR; O95628; -.
DR   BioGrid; 110912; 18.
DR   IntAct; O95628; 11.
DR   STRING; 9606.ENSP00000445508; -.
DR   iPTMnet; O95628; -.
DR   PhosphoSitePlus; O95628; -.
DR   BioMuta; CNOT4; -.
DR   MaxQB; O95628; -.
DR   PaxDb; O95628; -.
DR   PeptideAtlas; O95628; -.
DR   PRIDE; O95628; -.
DR   Ensembl; ENST00000315544; ENSP00000326731; ENSG00000080802. [O95628-1]
DR   Ensembl; ENST00000361528; ENSP00000354673; ENSG00000080802. [O95628-8]
DR   Ensembl; ENST00000414802; ENSP00000416532; ENSG00000080802. [O95628-5]
DR   Ensembl; ENST00000423368; ENSP00000406777; ENSG00000080802. [O95628-4]
DR   Ensembl; ENST00000428680; ENSP00000399108; ENSG00000080802. [O95628-2]
DR   Ensembl; ENST00000451834; ENSP00000388491; ENSG00000080802. [O95628-9]
DR   Ensembl; ENST00000541284; ENSP00000445508; ENSG00000080802. [O95628-10]
DR   GeneID; 4850; -.
DR   KEGG; hsa:4850; -.
DR   UCSC; uc003vss.4; human. [O95628-1]
DR   CTD; 4850; -.
DR   DisGeNET; 4850; -.
DR   GeneCards; CNOT4; -.
DR   H-InvDB; HIX0007112; -.
DR   HGNC; HGNC:7880; CNOT4.
DR   HPA; HPA005737; -.
DR   MIM; 604911; gene.
DR   neXtProt; NX_O95628; -.
DR   OpenTargets; ENSG00000080802; -.
DR   PharmGKB; PA26675; -.
DR   eggNOG; KOG2068; Eukaryota.
DR   eggNOG; COG5175; LUCA.
DR   GeneTree; ENSGT00390000000068; -.
DR   HOGENOM; HOG000065696; -.
DR   HOVERGEN; HBG051043; -.
DR   InParanoid; O95628; -.
DR   KO; K10643; -.
DR   OMA; ASWNPYS; -.
DR   OrthoDB; EOG091G03YT; -.
DR   PhylomeDB; O95628; -.
DR   TreeFam; TF106134; -.
DR   Reactome; R-HSA-429947; Deadenylation of mRNA.
DR   Reactome; R-HSA-6804115; TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain.
DR   UniPathway; UPA00143; -.
DR   EvolutionaryTrace; O95628; -.
DR   GenomeRNAi; 4850; -.
DR   PRO; PR:O95628; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000080802; -.
DR   CleanEx; HS_CNOT4; -.
DR   ExpressionAtlas; O95628; baseline and differential.
DR   Genevisible; O95628; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003723; F:RNA binding; IDA:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome.
DR   GO; GO:0000289; P:nuclear-transcribed mRNA poly(A) tail shortening; TAS:Reactome.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   CDD; cd12438; RRM_CNOT4; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR034261; CNOT4_RRM.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR003954; RRM_dom_euk.
DR   InterPro; IPR000571; Znf_CCCH.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00076; RRM_1; 1.
DR   SMART; SM00361; RRM_1; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS50103; ZF_C3H1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Coiled coil; Complete proteome;
KW   Cytoplasm; Metal-binding; Methylation; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; RNA-binding; Transferase;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    575       CCR4-NOT transcription complex subunit 4.
FT                                /FTId=PRO_0000081679.
FT   DOMAIN      109    189       RRM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00176}.
FT   ZN_FING      14     57       RING-type; degenerate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00175}.
FT   ZN_FING     190    217       C3H1-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00723}.
FT   COILED       68    104       {ECO:0000255}.
FT   MOD_RES      71     71       Phosphoserine.
FT                                {ECO:0000244|PubMed:17525332}.
FT   MOD_RES     301    301       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     324    324       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231}.
FT   MOD_RES     432    432       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     475    475       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     483    483       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   MOD_RES     490    490       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES     497    497       Asymmetric dimethylarginine.
FT                                {ECO:0000244|PubMed:24129315}.
FT   VAR_SEQ       1     17       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_009923.
FT   VAR_SEQ     271    274       RYDT -> S (in isoform 2, isoform 8 and
FT                                isoform 9). {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|Ref.3}.
FT                                /FTId=VSP_009924.
FT   VAR_SEQ     419    433       IEKELSVQDQPSLSP -> TEPIERKRLAVLKRR (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:10637334}.
FT                                /FTId=VSP_009925.
FT   VAR_SEQ     434    575       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:10637334}.
FT                                /FTId=VSP_009926.
FT   VAR_SEQ     543    575       GEEEVKVSTMPLSTSSHSLQQGQQPTSLHTTVA -> DNSS
FT                                SIESLNMKEWQDGLRALLPNININFGGLPNSSSPSNANHSA
FT                                PTSNTATTDSLSWDSPGSWTDPAIITGIPASSGNSLDSLQD
FT                                DNPPHWLKSLQALTEMDGPSAAPSQTHHSAPFSTQIPLHRA
FT                                SWNPYPPPSNPSSFHSPPPQIYYRVQHWTAIRQRGATIRKC
FT                                RICPTLFSPSQPTTHSSLLISYVLKNPVPDQFFFSLTPDAM
FT                                RSQGHYHLFINCKNFC (in isoform 6).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_009927.
FT   VAR_SEQ     543    575       GEEEVKVSTMPLSTSSHSLQQGQQPTSLHTTVA -> DNSS
FT                                SVESLNMKEWQDGLRALLPNININFGGLPNSSSPSNANHSA
FT                                PTSNTATTDSLSWDSPGSWTDPAIITGIPASSGNSLDSLQD
FT                                DNPPHWLKSLQALTEMDGPSAAPSQTHHSAPFSTQIPLHRA
FT                                SWNPYPPPSNPSSFHSPPPGFQTAFRPPSKTPTDLLQSSTL
FT                                DRH (in isoform 9 and isoform 10).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045469.
FT   VAR_SEQ     544    575       EEEVKVSTMPLSTSSHSLQQGQQPTSLHTTVA -> IPASS
FT                                GNSLDSLQDDNPPHWLKSLQALTEMDGPSAAPSQTHHSAPF
FT                                STQIPLHRASWNPYPPPSNPSSFHSPPPGFQTAFRPPSKTP
FT                                TDLLQSSTLDRH (in isoform 4 and isoform
FT                                8). {ECO:0000303|Ref.1}.
FT                                /FTId=VSP_009928.
FT   VAR_SEQ     544    575       EEEVKVSTMPLSTSSHSLQQGQQPTSLHTTVA -> IPASS
FT                                GNSLDSLQDDNPPHWLKSLQALTEMDGQRCSITDPPQRPLQ
FT                                HTDPAAQSQLESLPSSFKPFQLPLPTPRLSDGLQTPQQNPH
FT                                RFTTEFNTGPPLGKEEQPLENAGFVPLCFLPLSPPPTAPFS
FT                                SLMF (in isoform 7). {ECO:0000303|Ref.7}.
FT                                /FTId=VSP_009929.
FT   VARIANT       7      7       A -> G (in dbSNP:rs17480616).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_027833.
FT   MUTAGEN      16     16       L->A,E: Abolishes interaction with E2
FT                                ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   MUTAGEN      17     17       C->A: Abolishes interaction with E2
FT                                ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   MUTAGEN      18     18       M->A: Strongly reduces interaction with
FT                                E2 ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   MUTAGEN      33     33       C->R: Abolishes interaction with E2
FT                                ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   MUTAGEN      42     42       W->A: Strongly reduces interaction with
FT                                E2 ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   MUTAGEN      44     44       R->A,E: Strongly reduces interaction with
FT                                E2 ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   MUTAGEN      45     45       I->A,W: Strongly reduces interaction with
FT                                E2 ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   MUTAGEN      49     49       E->A: Strongly reduces interaction with
FT                                E2 ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428,
FT                                ECO:0000269|PubMed:15001359}.
FT   MUTAGEN      49     49       E->K: Strongly reduced interaction with
FT                                UBE2D2. {ECO:0000269|PubMed:11823428,
FT                                ECO:0000269|PubMed:15001359}.
FT   MUTAGEN      54     54       P->A: Strongly reduces interaction with
FT                                E2 ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   MUTAGEN      57     57       R->A,E: Strongly reduces interaction with
FT                                E2 ubiquitin ligases.
FT                                {ECO:0000269|PubMed:11823428}.
FT   CONFLICT    178    178       N -> D (in Ref. 4; BAH13270).
FT                                {ECO:0000305}.
FT   CONFLICT    201    201       K -> R (in Ref. 4; BAH13270).
FT                                {ECO:0000305}.
FT   CONFLICT    340    340       N -> I (in Ref. 6; AAH35590).
FT                                {ECO:0000305}.
FT   CONFLICT    570    570       L -> F (in Ref. 1; AAD00179/AAD00180).
FT                                {ECO:0000305}.
FT   TURN         15     17       {ECO:0000244|PDB:1E4U}.
FT   TURN         23     27       {ECO:0000244|PDB:1E4U}.
FT   HELIX        39     45       {ECO:0000244|PDB:1E4U}.
FT   TURN         54     56       {ECO:0000244|PDB:1E4U}.
SQ   SEQUENCE   575 AA;  63510 MW;  C41762D4EC4222BC CRC64;
     MSRSPDAKED PVECPLCMEP LEIDDINFFP CTCGYQICRF CWHRIRTDEN GLCPACRKPY
     PEDPAVYKPL SQEELQRIKN EKKQKQNERK QKISENRKHL ASVRVVQKNL VFVVGLSQRL
     ADPEVLKRPE YFGKFGKIHK VVINNSTSYA GSQGPSASAY VTYIRSEDAL RAIQCVNNVV
     VDGRTLKASL GTTKYCSYFL KNMQCPKPDC MYLHELGDEA ASFTKEEMQA GKHQEYEQKL
     LQELYKLNPN FLQLSTGSVD KNKNKVTPLQ RYDTPIDKPS DSLSIGNGDN SQQISNSDTP
     SPPPGLSKSN PVIPISSSNH SARSPFEGAV TESQSLFSDN FRHPNPIPSG LPPFPSSPQT
     SSDWPTAPEP QSLFTSETIP VSSSTDWQAA FGFGSSKQPE DDLGFDPFDV TRKALADLIE
     KELSVQDQPS LSPTSLQNSS SHTTTAKGPG SGFLHPAAAT NANSLNSTFS VLPQRFPQFQ
     QHRAVYNSFS FPGQAARYPW MAFPRNSIMH LNHTANPTSN SNFLDLNLPP QHNTGLGGIP
     VAGEEEVKVS TMPLSTSSHS LQQGQQPTSL HTTVA
//
